2022 EHA | 中国专家国际发声，124篇Poster入选！（一）

第27届欧洲血液学年会（EHA）将于2022年6月9日~12日以线上+线下的形式召开，会议由欧洲血液学会主办。作为欧洲血液学领域规模最大的国际会议，每年都有来自全球100多个国家的10000余名专业人士与会，一起分享并探讨有关血液学的创新理念及最新的科学和临床研究成果。随着中国临床研究的快速发展，中国在世界血液学领域也发挥着日益重要的作用，在新冠疫情大背景下，更是为世界血液科医生提供了宝贵的患者管理经验。今年，中国专家有69篇Poster以及55篇ePoster入围EHA年会，让我们一起盘点一下吧。

2022 EHA 中国专家Poster汇总

1.摘要号：P322

题目：THERAPEUTIC EFFECT OF TARGETING CASEIN KINASE II / WDR5 AXIS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

报告人：葛峥

单位：东南大学附属中大医院

2.摘要号：P349

题目：CLONAL ARCHITECTURE DISSECTING AT SINGLE-CELL RESOLUTION REVEALS MECHANISMS OF CHEMOTHERAPY RESISTANCE AND RELAPSE IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA

报告人：Jingliao Zhang

单位：中国医学科学院血液病医院

3.摘要号：P358

题目：COMPREHENSIVE DIAGNOSTICS OF ACUTE LYMPHOBLASTIC LEUKEMIA BY WHOLE TRANSCRIPTOME RNA SEQUENCING

报告人：Jing Li

4.摘要号：P370

题目：EARLY RESULTS OF A SAFETY AND EFFICACY STUDY OF ALLOGENEIC TRUUCAR™ GC502 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL)

报告人：黎诗琦

单位：解放军联勤保障部队902医院

5.摘要号：P378

题目：THE PROGNOSIS FACTORS OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-ALL

报告人：胡星星

单位：陕西省人民医院

6.摘要号：P393

题目：SYNERGISTIC EFFECT OF EZH2 INHIBITOR WITH BCL2 INHIBITOR BY ENHANCING PIK3IP1 EXPRESSION IN ACUTE MYELOID LEUKEMIA

报告人：葛峥

单位：东南大学附属中大医院

7.摘要号：P407

题目：SYNERGISTIC EFFECT OF A NOVEL COMBINATION OF HDACI CHIDAMIDE WITH CLADRIBINE ON CELL PROLIFERATION ARREST AND APOPTOSIS IN ACUTE MYELOID LEUKEMIA BY TARGETING MYC/HDAC2 SIGNALING

报告人：葛峥

单位：东南大学附属中大医院

8.摘要号：P469

题目：CHEMORESISTANCE IN ACUTE MYELOID LEUKEMIA: A SINGLE-CELL RNA SEQUENCING APPROACH

报告人：Chieh-Lin Teng

单位：台中荣民总医院

9.摘要号：P486

题目：CD9 MARKS DIFFERENTIATION AND ANTI-TUMOR IMMUNITY IN PEDIATRIC ACUTE MYELOID LEUKEMIA

报告人：Yaqun Xu

单位：香港中文大学

10.摘要号：P488

题目：THZ1, A COVALENT CDK7 INHIBITOR, INDUCES APOPTOSIS IN ACUTE MYELOID LEUKEMIA CELLS AND EXERTS SYNERGISTIC ANTILEUKEMIA ACTIVITY WITH AZACITIDINE

报告人：张帅

单位：北京医院

11.摘要号：P516

题目：ADULT LANGERHANS CELL HISTIOCYTOSIS WITH THYROID GLAND INVOLVEMENT:CLINICAL PRESENTATION，GENOMIC ANALYSIS AND OUTCOME

报告人：蔡华聪

单位：北京协和医院

12.摘要号：P533

题目：SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA DEMETHYLATION AGENT +CAG REGIMENIN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA：INTERIM ANALYSIS

报告人：高晓宁

单位：中国人民解放军总医院第五医学中心

13.摘要号：P549

题目：ANALYSIS OF THE CLINICAL SIGNIFICANCE AND PROGNOSTICIMPACT OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM 11762V IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

报告人：吕晓东

单位：河南省肿瘤医院

14.摘要号：P560

题目：ANALYSIS OF GENE MUTATION SPECTRUM AND CORRELATION BETWEEN GENETIC ABNORMALITIES IN 207

PATIANTS WITH T（8；21）AML

报告人：anbo Nie

15.摘要号：P588

题目：IMPROVED OUTCOME OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA BY ADDITION OF LIPOSOMAL ADRIAMYCIN TO CLAG CHEMOTHERAPY

报告人：姚洽

单位：陆军军医大学第二附属医院（新桥医院）

16.摘要号：P591

题目：PRELIMINARY RESULTS OF A PHASE I STUDY OF CLIFUTINIB，A HIGHLY SELECTIVE，POTENT ORAL FLT-3 INHIBITOR，IN PATINETS WITH FLT3-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

报告人：金洁

单位：浙江大学附属第一医院

17.摘要号：P610

题目：SYNERGISTIC ACTIVITY OF FTO INHIBITOR FB23-2 WITH IBRUTINIB IN XENOGRAFT MURINE MODEL OF CHRONIC LYMPHOCYTIC LEUKEMIA报告人：Xinting Hu单位：山东省立医院

18.摘要号：P684

题目：PHASE 1 STUDY OF LP-108，A SELECTIVE BCL-2 INHIBITOR，IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

报告人：徐卫

单位：江苏省人民医院

19.摘要号：P710

题目：CLINICAL STUDY ON THE RELATIONSHIP BETWEEN NON-ABL1 KINASE REGION MUTATION AND TKI DRUG RESISTANCE AND DISEASE PROGRESSION IN CHRONIC MYELOID LEUKEMIA

报告人：吕晓东

单位：河南省肿瘤医院

20.摘要号：P721

题目：PREDICTIVE SCORING SYSTEMS FOR MOLECULAR RESPONSES IN PERSONS WITH CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL IMATINIB THERAPY

报告人：张小帅

单位：北京大学人民医院

21.摘要号：P722

题目：IS THE SECOND-GENERATION TYROSINE KINASE INHIBITOR A BETTER THERAPY THAN IMATINIB FOR PERSONS WITH CHRONIC MYELOID LEUKEMIA PRESENTING IN ACCELERATED-PHASE？

报告人：张小帅

单位：北京大学人民医院

22.摘要号：P733

题目：DHX9 HELICASE DYSFUNCTION CONTRIBUTES TO DISEASE PROGRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

报告人：许峰

单位：上海市第六人民医院

23.摘要号：P736

题目：BCOR MUTATION REGULATES MYELODYSPLASTIC SYNDROMES PROGRESSION THROUGH REPRESSING AUTOPHAGY FLUX MEDIATED BY HDAC6 ACTIVATION

报告人：吴凌云

单位：上海市第六人民医院

24.摘要号：P753

题目：DYSFUNCTIONAL BONE MARROW ENDOTHELIAL PROGENITOR CELLS ARE INVOLVED IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

报告人：Tong Xing

单位：北京大学人民医院

25.摘要号：P773

题目：THE ELEVATION OF RED BLOOD CELL DISTRIBUTION IS AN INDEPENDENT PROGNOSTIC FACTOR FOR JUVENILE MYELOMONOCYTIC LEUKEMIA

报告人：Weiru Liang

单位：中国医学科学院北京协和医学院

26.摘要号：P811

题目：A SINGLE CENTER HISTORICAL CONTROL STUDY OF ELTROMBOPAG ADDED TO IMMUNOSUPPRESSIVE THERAPY FOR SEVEREAPLASTIC ANEMIA IN CHILDREN

报告人：Bixi Yang

单位：首都医科大学附属北京儿童医院

27.摘要号：P880

题目：OVEREXPRESSION OF PFKFB4 PROMOTES ADAPTATION TO HYPOXIC MICROENVIRONMENT IN MULTIPLE MYELOMA

报告人：Jie Yang单位：东南大学附属中大医院

28.摘要号：P895

题目：DARATUMUMAB，BORTEZOMIB，AND DEXAMETHASONE（D-VD）VERSUS BORTEZOMIB AND DEXAMETHASONE（VD）ALONE IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA（RRMM）：UPDATED ANALYSIS OF LEPUS

报告人：傅卫军

单位：上海长征医院

29.摘要号：P896

题目：DEVELOPMENT AND VALIDATION OF A FRAILTY PREDICTION MODEL MORE SUITABLE FOR MULTIPLE MYELOMA IN CHINESE PATIENTS:THE TM FRAILTY SCORE.

报告人：李娟

单位：中山大学附属第一医院

30.摘要号：P910

题目：DOES MINIMAL RESIDUAL DISEASE OF STEM CELL COLLECTION HAVE PROGNOSTIC IMPACT ON PATIENTS WITH MULTIPLE MYELOMA？

报告人：Xu Jingyu

单位：中国医学科学院血液病医院

31.摘要号：P953

题目：PHASEI STUDY OF TQB3602 CAPSULE，AN ORAL PROTEASOME INHIBITOR，IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

报告人：牛挺

单位：四川大学华西医院

32.摘要号：P974

题目：THE CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH PRIMARY PLASMA CELL LEUKEMIA（PPCL）UNDER THE NEW IWMG DEFINITION CRITERIA

报告人：唐文娇

单位：中国医学科学院血液病医院

33.摘要号：P976

题目：BENDAMUSTINE-POMALIDOMIDE-DEXAMETHASONE（BPD）FOR RELAPSED AND/OR REFRACTOR MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE报告人：钟玉萍

单位：青岛市市立医院

34.摘要号：P1004

题目：EFFECT AND MOLECULAR MECHANISM OF TQ05105，A NOVEL SMALL MOLECULE INHIBITOR OF JAK2 IN MYELOPROLIFERATIVE NEOPLASM

报告人：Wenjun Zhang单位：中国医学科学院血液病医院

35.摘要号：P1067

题目：PHASE 2 STUDY OF ORAL THALIDOMIDE-CYCLOPHOSPHAMIDE-DEXAMETHASONE FOR RECURRENT/REFRACTORY ADULT LANGERHANS CELL HISTIOCYTOSIS

报告人：Ji-nuo Wang

单位：北京协和医院

36.摘要号：P1072

题目：NATURAL HISTORY OF JUVENILE MYELOMONOCYTIC LEUKEMIA

报告人：Wenyu Yang

单位：中国医学科学院血液病医院

37.摘要号：P1173

题目：CLINICAL APPLICABILITY OF TARGETED NEXT-GENERATION SEQUENCING FOR PRECISION MEDICINE IN DIFFUSE LARGE B CELL LYMPHOMA

报告人：黄德鸿

单位：重庆大学附属肿瘤医院

38.摘要号：P1192

题目：ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL

报告人：宋玉琴

单位：北京大学肿瘤医院

39.摘要号：P1199

题目：MACHINE-LEARNING ALGORITHM TO DETECTION OF LYMPHOMA WITH BONE MARROW INVOLVEMENT VIA FDG-18 PET/CT

报告人：Cho-Hao Lee

单位：三军总医院

40.摘要号：P1201

题目：ZANUBRUTINIB PLUS RCHOP（ZR-CHOP）REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA

报告人：李增军

单位：山东省肿瘤医院

41.摘要号：P1205

题目：PROGNOSTIC ROLE OF TUMOR P53 MUTATION IN DIFFUSE LARGE B CELL LYMPHOMA:A SYSTEMATIC REVIEW AND META-ANALYSIS

报告人：马骥

单位：山东省肿瘤医院

42.摘要号：P1206

题目：GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA

报告人：胡凯

单位：北京高博博仁医院

43.摘要号：P1216

题目：ZANUBRUTINIB PLUS R-CHOP（RI-CHOP）AS THE TREATMENT FOR DOUBLE EXPRESSION OF MYC/BCL2 IN PATIENTS WITH DIFFUSED LARGE B-CELL LYMPHOMA

报告人：任柯星

单位：四川大学华西医院

44.摘要号：P1218

题目：FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GCO12F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA

报告人：陈新锋

单位：郑州大学第一附属医院

45.摘要号：P1236

题目：EFFICACY AND TOXICITY FOR CD7 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY T-CELL LYMPHOMA

报告人：胡凯

单位：北京高博博仁医院

46.摘要号：P1237

题目：PRELIMINARY RESULTS OF A PHASE I STUDY OF ZANUBRUTINIB COMBINED WITH IMMUNOCHEMOTHERAPY IN PATIENTS WITH CD79A/CD79B-MUTANT DIFFUSE LARGE B-CELL LYMPHOMA

报告人：姚志华

单位：河南省肿瘤医院

47.摘要号：P1238

题目：EFFICACY ANALYSIS OF PEGASPARGASE，GEMCITABINE，OXALIPLATIN，DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA

报告人：朱尊民

单位：河南省人民医院

48.摘要号：P1240

题目：ANTI-PD-1-ANTIBODY（TISLELIZUMAB）COMBINED WITHDEACETYLASE INHIBITOR（CHIDAMIDE），LENALIDOMIDE ANDETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA，NASAL

报告人：张蕾

单位：郑州大学第一附属医院

49.摘要号：P1241

题目：THE INCIDENCE AND SURVIVAL OUTCOMES OF PATIENTS WITH PRIMARY GASTRIC T-CELL LYMPHOMA:A SEER POPULATION-BASED STUDY

报告人：张曼玥

单位：上海交通大学医学院附属仁济医院

50.摘要号：P1242

题目：ZANUBRUTINIB AND RITUXIMAB REGIMEN COMBINED WITH INTRAVITREAL METHOTREXATE FOLLOWED BY ZANUBRUTINIB MAINTENANCE FOR TREAT-NAIVE PRIMARY VITREORETINAL LYMPHOMA:A PROSPECTIVE PHASE II STUDY

报告人：张炎

单位：北京协和医院

51.摘要号：P1311

题目：GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION FACILITATES ANTI-GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA EFFECTSOF MUCOSA-ASSOCIATED INVARIANT T CELLS THROUGH DISTINCT FUNCTIONAL SUBSE

报告人：高梦鸽

单位：北京大学人民医院

52.摘要号：P1386

题目：A REVIEW OF HEMATOPOIETIC CELL TRANSPLANTATION IN TAIWAN:DATA AND TRENDS DURING 2009-2018

报告人：Yu-Hung Wang

单位：国立台湾大学医学院附设医院

53.摘要号：P1393

题目：HIGHER DOSE OF CD34+ CELLS PROMOTES EARLY RECONSTITUTION OF NATURAL KILLER CELLS AND IS ASSOCIATED WITH BETTER OUTCOMES AFTER UNMANIPULATED HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MYELOID MALIGNAN

报告人：Fei Zhao

单位：中国医学科学院血液病医院

54.摘要号：P1394

题目：DIFFERENT DOSES OF ANTITHYMOCYTE GLOBULIN（ATG）AS PART OF THE PREPARATIVE REGIMEN INHEMATOPOIETIC STEM CELL TRANSPLANTATION（HSCT）

报告人：熊敏

单位：北京陆道培医院

55.摘要号：P1364

题目：HLA MISMATCHED UNRELATED STEM CELL TRANSPLANTATION USING ANTITHYMOCYTE GLOBULIN IS A SUITABLE ALTERNATIVE FOR PATIENTS LACKING HLA-MATCHED UNRELATED DONORS:SINGLE CENTER LONG-TERM FOLLOW-UP DATA ANAL

报告人：高蕾

单位：陆军军医大学第二附属医院（新桥医院）

56.摘要号：P1370

题目：EFFECTS OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL FROM HEALTHY DONORS ON RECIPIENTS AFTER TRANSPLANTATION AND RELATED RESEARCH

报告人：Biao Shen

单位：中国医学科学院血液病医院

57.摘要号：P1385

题目：THE GUIDING SIGNIFICANCE OF IMMUNE CELL SUBSET MONITORING IN IMMUNE RECONSTITUTION IN PATIENTS WITH CAR-T BRIDGED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

报告人：赵玮

单位：北京陆道培医院

58.摘要号：P1392

题目：MACHINE LEARNING ALGORITHM AS A PROGNOSTIC TOOL FOR VENOUS THROMBOEMBOLISM IN ALLOGENIC TRANSPLANT PATIENTS

报告人：邓睿歆

单位：北京大学人民医院

59.摘要号：P1422

题目：IN VIVO G-CSF TREATMENT ACTIVATES THE GR-SOCS1 AXIS TO SUPPRESS IFN-T SECRETION BY NATURAL KILLER CELLS

报告人：Xunhong Cao

单位：北京大学人民医院

60.摘要号：P1440

题目：BTK INHIBITORS IMPROVE CART19 CELL THERAPY BY MODULATING IMMUNE SYSTEM

报告人：梅恒

单位：华中科技大学同济医学院附属协和医院

61.摘要号：P1441

题目：SINGLE-CELL TRANSCRIPTOMIC CHARACTERIZATIONS OF BONE MARROW MONONUCLEAR CELLS AND CAR-T PRODUCTS ASSOCIATED WITH EFFICACY AND TOXICITY IN B-ALL PATIENTS

报告人：梅恒

单位：华中科技大学同济医学院附属协和医院

62.摘要号：P1643

题目：EFFICACY OF RECOMBINANT HUMANTHROMBOPOIETIN ON CHILDREN IMMUNE THROMBOCYTOPENIA AND ITS INFLUENCING FACTORS

报告人：马静瑶

单位：首都医科大学附属北京儿童医院

63.摘要号：P1650

题目：METABOLIC ABNORMALITY AND GLUCOCORTICOID RECEPTOR MODULATION OF MYELOID-DERIVED SUPPRESSOR CELLS IN IMMUNE THROMBOCYTOPENIA PATIENTS AND AN ACTIVE MURINE MODEL

报告人：Shuwen Wang

单位：山东大学

64.摘要号：P1651

题目：HDAC3 RS2530223 IS ASSOCIATED WITH INCREASED SUSCEPTIBILITY AND SEVERITY OF PRIMARY IMMUNE THROMBOCYTOPENIA

报告人：Shuwen Wang

单位：山东大学

65.摘要号：P1652

题目：MACHINE-LEARNING-BASED MORTALITY PREDICTION OF ICH IN ADULTS WITH ITP:A NATIONWIDE REPRESENTATIVE MULTICENTRE STUDY

报告人：Shan Chong

单位：北京大学人民医院

66.摘要号：P1653

题目：CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC

报告人：Xuan Cai

单位：北京大学人民医院

67.摘要号：P1654

题目：COMPLEMENT ACTIVATION REGULATES PLATELET HOMEOSTASIS BY ARRESTING THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN-35 IN IMMUNE THROMBOCYTOPENIA

报告人：Yejun Wu

单位：北京大学血液研究所

68.摘要号：P1655

题目：PERSONALIZED MACHINE-LEARNING-BASED PREDICTION FOR CRITICAL IMMUNE THROMBOCYTOPENIA BLEEDS:A NATIONWIDE DATA STUDY

报告人：Zhuo-Yu An

单位：北京大学人民医院

69.摘要号：P1662

题目：OPTIMIZED PROPHYLAXIS BASED ON INDIVIDUALIZED TARGET TROUGH FVII LEVEL IN PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIAA

报告人：Kun Huang

单位：首都医科大学附属北京儿童医院

注：排名不分先后，按照摘要号进行，如有遗漏，请给我们留言~